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Abstract

Introduction

The aim of this study was to examine the effect of
sodium pentosan polysulfate (SPP) in an undiluted urine
system and to study its relative affinity to calcium
oxalate (CaOx) crystals in the presence or absence of
heparan sulfate (HS). CaOx crystals were induced with
an overload of oxalate above the metastable limit in spun
and filtered urine (SF) and ultrafiltered urine (UF).
Then, the crystals were dissolved with EDT A (ethylenediaminetetraacetic acid), electrodialysed and lyophilized.
The polyanions, HS or SPP were added to the UF prior
to the addition of oxalate. Polyanions in crystal matrices
were examined by cellulose acetate electrophoresis.
Crystal volume and size were suppressed according to
the increase of the concentration of SPP when compared
with those of the UF. Scanning electron microscopy
(SEM) showed marked aggregation of the crystals in the
UF and no aggregation in the presence of SPP. HS was
the only polyanion found in CaOx crystals formed after
overload of oxalate in SF. Crystals formed in UF did
not contain any polyanions. When SPP was added to
UF, SPP appeared in the crystal matrix in accordance
with its concentration. Once HS in physiological concentration was added to the UF containing SPP, HS and
SPP obtained from crystals were strongly stained with
Alcian blue in electrophoretic study, where SPP is
stained stronger than HS. These results suggest that
SPP strongly binds to CaOx crystals as well as HS and
that HS and SPP competitively bind to the crystal, then,
as a result, they are incorporated into the crystals. The
fact that SPP suppressed the aggregation of CaOx crystals in undiluted urine showed the possibility that SPP
might be one of the useful drugs for preventing CaOx
urolithiasis.

Though a number of studies have clarified that some
macromolecules are inhibitors of calcium oxalate (CaOx)
crystalliz.ation, the role of macromolecules in the formation of CaOx stones remains unclear [15]. It is well
known that glycosaminoglycans (GAGs) as well as proteins are present in the matrices of urinary stones [2, 12,
20, 38]. In normal urine, chondroitin sulfate (ChS) is
the most abundant GAG at 60% and HS accounts for
15% [9]. The pattern of GAGs in stones differs from
that in urine. Nishio et al. [23] reported that hyaluronic
acid (HA) and heparan sulfate (HS) were extracted from
the matrices of CaOx stones. Roberts and Resnick [29]
reported that ChS was usually absent from urinary stone
matrix and the two of GA Gs in stones were HS and HA.
Iwata reported the presence of HS in the matrix of uric
acid crystals [14].
At present there are few reports about GAGs in the
matrix of CaOx crystals. Yamaguchi et al. [46]
reported that HS was the major GAG in CaOx crystal
matrix. We found that HS was the only GAG in the
newly formed CaOx crystals in spun and filtered urine
(SF) and showed strong inhibition against crystal aggregation in undiluted urine. Moreover, HS was shown to
be selectively included into crystals due to its relative
binding affinity [44] . Sodium pentosan polysulfate
(SPP) is a semi-synthetic polyanion and reported to be
a strong inhibitor of CaOx crystalliz.ation [4, 6, 17, 19,
24, 25, 26, 41]. The role of SPP in an undiluted urine
system as well as in crystal matrices has not been reported in the literature. In this paper, we report on the
crystal size distribution and the analysis of the polyanions in the matrix of newly formed CaOx crystals in
the presence of SPP. We also examined the interaction
of HS and SPP using an ultrafiltered urine system, and
evaluated it by electrophoresis and scanning electron
microscopy (SEM).

Key Words: Urinary glycosaminoglycans, sodium pentosan polysulfate, heparan sulfate, calcium oxalate
crystals, crystal aggregation, undiluted urine system.
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Materials
All reagents were of analytical grade. SPP, heparan
sulfate and Alcian blue 8 GX were obtained from Sigma
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overnight at 4 °C (3 times), and lyophilized. Crystal
matrix extract was dissolved in d.d. water and desalted
with an Econo-Pac lODG column (6 kDa cut off; BIORAD Co., Tokyo, Japan) and lyophilized. All the steps
were repeated 6 times. Only mean values of results are
depicted.

Chemical Co. (Tokyo, Japan). Cellulose acetate strips
(CA-25010, 25 x 160 mm) were obtained from Schleicher and Schell (Dassel, Germany).

Collection and preparation of urine samples
Twenty-four hour urine specimens were collected
from 5 healthy men aged 30-43 years old, then pooled.
None showed any sign of blood by chemical test. Urine
specimens were centrifuged at 6,000 X g for 60 minutes
(RS-206, TOMY, Tokyo, Japan) and filtered through 8
µm followed by 0.22 µm Millipore GV filters (Millipore
Corp., Bedford, MA, USA), being used as SF (spun and
filtered urine), then ultrafiltered using hollow fiber
bundle (AIP-1010, Asahikasei KK, Tokyo, Japan) with
a nominal molecular cut-off of 10 kDa (UF; ultrafiltered
urine). Urine samples were refrigerated until needed
and were warmed to 37°C and refiltered (0.22 µm) just
prior to use. Each 100 ml urine was prepared for
further experiment.

Electrophoresis
Two µl of dissolved samples (20 µg/20 µl of distilled water) were applied to cellulose acetate strips and
electrophoresed at 80 V for 45 minutes. 0.2 M calcium
acetate (pH 7.2) was used as a buffer solution [16, 45].
As a reference, HS and SPP (each in 1 µg/µl) were run
simultaneously in wide mini sub cell (BIO-RAD). Cellulose acetate strips were stained in 0.2 per cent Alcian
blue 8 GX solution containing 0.05 M magnesium chloride, 0.025 M sodium acetate, 50% ethanol and 50%
deionized water for 15 minutes and destained in same
solution without Alcian blue for 120 minutes with 6
changes of destaining solution. A laser densitometer
(Ultroscan XL, Pharmacia Biotech, Tokyo, Japan) was
used to determine the relative content of each GAG.
This experiment was repeated 6 times. In the case of
protein rich urine, papain digestion was performed.
Heparitinase was used to digest HS.

Crystal preparation
The method of inducing CaOx crystallization in undiluted urine has been described elsewhere [5, 34, 35].
Briefly, the minimum amount of oxalate required to produce crystals in 200 µI of urine by adding 2 µI of graded
concentration series of sodium oxalate was used to determine the metastable limit by microplate and inverted
microscopy [42]. Once the metastable limit had been
measured, an amount of oxalate, 0.3 mmol/1 (final concentration) in excess of this limit, was added to urine
specimens drop-wise! y. A Coulter counter (Model TA
II, fitted with a NEC personal computer, aperture size;
100 µm; Coulter Co. , Tokyo, Japan) was used to monitor the crystal particle size every ten minutes during a
90 minute incubation period in a 37°C shaking water
bath. After 90 minute incubation, samples for SEM
were prepared. The same amount of oxalate was added
after 90 minutes and 120 minutes to increase the yield of
CaOx crystals.
Into UF specimens, 0, 1, 2 and 10 µg/ml of SPP
and/or HS were added just prior to use.

Scanning electron microscopic (SEM) study
Urine samples for SEM were prepared at 90 minutes incubation. Each 500 µ1 urine was filtered on the
0.22 µm (10 mm) Millipore filter. Crystals on the filter
were dried in a desiccator at room temperature, then
mounted on stub and coated for SEM. The stubs were
examined with a JEOL-JSM 840 (JEOL, Tokyo, Japan)
SEM operated at an accelerating voltage of 15 kV, a
probe current of 6 x 10-9 A, and a working distance of
15 mm.

Results
SF and UF as well as UF that contained HS(UF +
HS) or UF that contained SPP(UF + SPP) showed the
same metastable limit. The volume of additional oxalate
required to form crystals was same in each solution.
Crystal volume of UF was significantly increased in accordance with time (Fig. 1). UF +SPP showed a slightly lower volume after 10 minutes compared with UF.
SF urine showed a significantly lower volume compar~
with UF or UF + SPP. Figure 2 shows crystal size-voiume distribution at 90 minutes incubation. In UF, crystal size and volume were larger than in UF + SPP and
SF.
The HS (1 µglµI) standard clearly identified on cellulose acetate strip was completely digested and disappeared from the strip by the use of heparitinase.
Crystals derived from each 100 ml of SF contained HS
only. This band showed the same migration distance

Isolation of crystal matrix
The crystals were washed on a 0.22 µm Millipore
filter, 6 times with 0.1 M sodium hydroxide, and then
with deionized and double distilled (d.d.) water to wash
out surface substances completely, lyophilized, weighed
and demineralized by the addition of 100 ml of 0.25 M
EDTA (ethylenediaminetetraacetic acid; pH 8.0) to
every 1 gram of crystals at 4 °C.
The solution of demineralized crystal extracts was
electrodialysed in the dialysis tube (Sigma, 10 kDa cut
off) against 25 mM Tris, 192 mM glycine buffer (pH
8.3) with 4 changes of the buffer at 80 V initially, with
a gradual increase to 120 V, then against d.d. water
1090
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Figures 1 and 2. Crystal volume according to time
course measured by Coulter counter (Fig. 1). Crystal
size distribution at 90 minutes after load of oxalate
measured by Coulter counter (Fig. 2). UF: ultrafiltered
urine; SPPl, 2, 10: UF containing SPP at final concentrations of 1, 2, and 10 µglml, respectively; S&F: spun
and filtered urine.
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SPP and HS included in crystal matrix at each concentration (µg/ml) of applied HA and/or SPP (Fig. 3A) .
HS: heparan sulfate; SPP: sodium pentosan polysulfate.
Densitometric analysis of Alcian-blue stained electrophoretic profile of HS and SPP at the concentration of
1 µg/ µ1 as standards (Fig. 3B).
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Figure 5. Scanning electron micrographs of calcium oxalate crystals formed in various concentrations of SPP (0, 1,
2, and 10 µg/ml) and HS (0, 1 and 2 µg/ml) added to ultrafiltered urine (UF). SF: spun and filtered urine. (A) SPP
0 I HS 0 (UF); (B) SPP 1 / HS 0; (C) SPP 2 / HS 0; (D) SPP 10 / HS 0; (E) SPP 1 / HS 2; (F) SPP 2 / HS 2; (G)
SPP 10 / HS 2; and (H) SF.
Table 1. Concentration of HS and SPP added to
ultrafiltered urine.

when compared with the migration of standard and disappeared after heparitinase digestion and, though not
shown in Figure 2, still remained after protein digestion
using papain. In crystals derived from UF, no visible
GAG bands were seen. These findings were same as
previous report [44]. When SPP was added into UF in
final concentration of 1 µg/ml, a single GAG band was
observed. This band was considered to be the same as
SPP from the migration distance of standard.
In order to determine whether there might be a relationship between SPP and HS in forming the crystals,
another experiment was performed. Various concentrations (0, 1, 2, 10 µg/ml) of SPP and HS were added to
UF, then crystals were prepared in the same manner.
Table 1 shows each concentration of HS and SPP added
to UF. Figure 3A shows the results of electrophoresis
of GAGs from crystals. HS was found in crystals using
UF + HS in concentration of 1, 2, 10 µg/ml, as well as
SF. SPP from the samples of each concentration of 1,
2, 10 µg/ml was clearly stained (Fig. 3A) . GAG bands
obtained from crystal matrix were examined by the use
of densitometer. The densitometric result of electrophoresis when the mixture of HS and SPP at 1 µg/ml
were added to UF is demonstrated in Figure 3B. Densitometry of 1 µg/ml of HS and SPP showed that the average ratio of HS to SPP was 48 % to 52 %. The results
of relative percentage of HS and SPP contained in crystals are shown in Figure 4. At similar concentrations of
SPP, the relative content of HS increased in accordance
with its concentration. When the concentration of HS
and SPP was the same at 2 and 10 µg/ml, it is apparent
that the amount of HS incorporated into the crystals decreased in relation to increasing concentrations of SPP.
This effect is most noticeable at the concentration of 10

HS (µg/ml)

SPP
(µg/ml)

0
1

1
1/1

2
10

2/1
10/1

2
1/2
2/2
10/2

10
1/10
2/10
10/10

Scanning electron micrographs were obtained at
each experiment (Fig. 5). In all samples, CaOx dihydrate crystals were precipitated. Interesting results were
obtained from SEM study. In UF, CaOx dihydrate crystals were formed and most of them were aggregated,
which was confirmed in crystal size analysis shown in
Figure 2. With increasing concentration of SPP, the
crystals were shown not to be aggregated. HS showed
almost the same results as those of SPP. Addition of
HS at the concentration of 2 µg/ml to UF + SPP showed
minimal aggregation which is thought to be almost same
as SF. In SF, most of the crystals were single and
somewhat aggregated.
Discussion

An undiluted urine seems to be the best system to
observe the affinity of macromolecules for CaOx crystals that might have inhibitory activity. Though many
macromolecular substances have been reported to efficiently inhibit growth or aggregation of CaOx crystals
[35), undiluted urine may help to determine their relative
inhibitory power. Though chondroitin sulfate (ChS),
which is the most abundant GAG in normal urine, is reported to inhibit crystal aggregation and growth when

µglml.
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urine at about 3 % of the oral dose [28]. Since the usual
dose is 300 to 400 mg/day, the calculated excretion rate
rises above 10 mg/I, that is enough to inhibit crystal
aggregation.
About clinical use, Fellstrom et al. [8] reported SPP
had a role in the treatment of recurrent stone disease
from the results that 48 % of the patients became stone
free and half of the patients who continued to form
stones had smaller ones which were easily passed.
Though complete prevention was not obtained, their trial
was thought to be valuable and the use of SPP might be
beneficial.
There are macromolecules other than HS in crystal
matrix [43]. Doyle et al. [5] have isolated a 31 kDa
crystal matrix protein (CMP) as a powerful inhibitor of
crystal aggregation. Further studies are required to
clarify the relationship between HS and CMP.
In summary, this study indicates that SPP is a potent
inhibitor of CaOx crystal aggregation and growth and
that SPP as well as HS are incorporated into crystals in
undiluted urine. The resultant relative content of SPP in
the crystal matrix was higher than that of HS .

used in seeded crystal system, it showed little or no inhibition against CaOx crystals in an undiluted urine system [36]. A previous study [44] clearly demonstrated
that HS was selectively incorporated into CaOx crystals
when using the undiluted urine system. ChS was included into crystals only when HS was added at O or 1
µglml.
In the normal concentration of urinary glycosaminoglycans, HS is a stronger inhibitor than ChS. From the
present study, HS and SPP bind the growing crystals
competitively. SPP is stronger than HS when these substances are used at the same concentration. Fellstrom et
al. [7] reported almost the same results. They measured
the relative binding affinities of GAGs to CaOx crystals
in organic media and reported that the inhibitory activity
of GAGs is largely a function of their charge density,
SPP > heparin > ChS. On the other hand, Angel and
Resnick [1] reported the binding affmity of CaOx crystals with various GAGs and obtained different results;
heparin > hyaluronic acid > ChS > SPP, though the
analytical method was different.
How GAGs are involved or incorporated into CaOx
crystals is unknown. Scurr and Robertson [39] reported
that heparin , ChS and RNA became negatively charged
in accordance with increasing concentration and this
resulted in the increase of negative zeta potential,
causing a repulsion between crystals and inhibition of
aggregation. More precise characterization of GAGs,
such as, charge or sulfation is needed to clarify the
genesis of crystal formation.
The studies of Robertson er al. [30, 31] suggest that
a reduction in inhibitory activity could be related to a
decrease of GAGs in about half of the cases of stone
formation. The difference of GAG excretion in urine
among the normal subjects and stone patients, has been
confirmed by subsequent investigations [3, 10, 13, 18,
21, 22, 32, 33, 37], though there was one report that no
difference existed between healthy persons and CaOx
stone patients [11]. Recently , Shum et al. [40] reported
that urinary HS of normal control subjects showed
higher inhibitory activity than that of stone formers.
SPP is reportedly a powerful inhibitor of CaOx
crystal aggregation and growth in seed crystal system [4,
6, 17, 19, 24, 25, 26, 41]. SPP is an anticoagulant now
used for treating interstitial cystitis [27]. Moreover,
SPP has the possibility of preventing stone formation .
In this report, we showed that SPP exists in crystals and
that SPP has an inhibitory role on growth and aggregation of CaOx crystals in undiluted urine. It is thus reasonable to assume that SPP might inhibit or prevent the
CaOx crystal formation, growth and aggregation in vivo.
HS and other macromolecules in urine could not be expected to increase from an oral load because of their
molecular weights. SPP is reportedly excreted in the

Acknowledgements

We express our sincere gratitude to Dr. Rosemary
L. Ryall (Department of Surgery, Flinders Medical
Centre, Australia) for her helpful advice.
References

[1] Angel AH, Resnick MI (1989). Surface interaction between glycosaminoglycans and calcium oxalate.
J Urol 141: 1255-1258.
[2] Boeve ER, Cao LC, Verkoelen CF, Romijn JC,
de Bruijn WC, Schroder FH (1994). Glycosaminoglycans and other sulfated polysaccharides in calculogenesis
of urinary stones. World J Urol 12: 43-48 .
[3] Caudarella R, Stefani F, Rizzoli E, Malavolta
N, D 'antuona G (1983) . Preliminary results of glycosaminoglycan excretion in normal and stone-forming subjects: Relationship with uric acid excretion. J Urol 129:
665-667 .
[4] Danielson BG, Fellstrom B, Wirkstrom B
(1989). Glycosaminoglycans as inhibitors of renal stone
formation. In: Urolithiasis. Walker VR, Sutton RAL,
Cameron ECB, Pak CYC, Robertson WG (eds.).
Plenum Press, New York. pp. 101-104.
[5] Doyle IR, Ryall RL, Marshall VR (1991). Inclusion of proteins into calcium oxalate crystals precipitated
from human urine: A highly selective phenomenon. Clin
Chem 37: 1589-1594.
[6] Fellstrom B, Danielson BG, Ljinghall S,
Wikstrom B (1985). The inhibition of calcium oxalate
1093

Koji Suzuki and Ryuzo Tsugawa
lithiasis. Nephron 62: 36-39.
[22] NikkiliiMT (1989). Urinary glycosaminoglycan
excretion in normal and stone-forming subjects: Significant disturbance in recurrent stone formers. Urol Int 44:
157-159.
[23] Nishio S, Abe Y, Wakatsuki A, Iwata H, Ochi
K, Takeuchi M, Matsumoto A (1985). Matrix glycosaminoglycan in urinary stones. J Urol 134: 503-505.
[24] Norman RW, Scurr DS, Robertson WG, Peacock M (1984). Inhibition of calcium oxalate crystallization by pentosan polysulfate in control subjects and stone
for.mers. Brit J Urol 56: 594-598.
[25] Norman RW, Scurr DS, Robertson WG, Peacock M (1984). Sodium pentosan polysulfate as a polyanionic inhibitor of calcium oxalate crystallization in
vitro and in vivo. Clin Sci 68: 369-371.
[26] Osswald H, Weinheimer G, Schutt I-D, Ernst
W (1989). Effective prevention of calcium-oxalate
crystal formation in vitro and in vivo by pentosan
polysulfate. In: Urolithiasis. Walker VR, Sutton RAL,
Cameron ECB, Pak CYC, Robertson WG (eds.).
Plenum Press, New York. pp. 141-144.
[27] Parsons CL (1982). Prevention of urinary tract
infection by the exogeneous glycosaminoglycan sodium
pentosan polysulfate. J Urol 172: 167-169.
[28] Parsons CL, Schmitt JD, Pollen JJ (1983). Successful treatment of interstitial cystitis with sodium
pentosanpolysulfate. J Urol 130: 51-53 .
[29] Roberts SD, Resnick MI (1986). Glycosaminoglycans content of stone matrix . J Urol 135: 1078-1083.
[30] Robertson WG , Peacock M, Marshall RW,
Marshall DH, Nordin BEC (1976). Saturation-inhibition
index as a measure of the risk of calcium oxalate stone
formation in the urinary tract. New Engl J Med 294:
249-252.
[31] Robertson WG, Peacock M, Heyburn PJ,
Marshall DH, Clark PB (1978). Risk factors in calcium
stone disease of the urinary tract. Br J Urol 50: 449454.
[32] Ryall RL, Marshall VR (1983). The value of
the 24-hour urine analysis in the assessment of stone
formers attending general hospital out patient clinic. Br
J Urol 55: 1-5.
[33] Ryal! RL, Marshall VR (1984). The relationship between urinary inhibitory activity and endogeneous
concentrations of glycosaminoglycans and uric acid:
comparison of urines from stone-formers and normal
subjects. Clin Chim Acta 141: 197-204.
[34] Ryall RL, Hibberd CM, Marshall VR (1985).
A method for studying inhibitory activity in whole urine.
Urol Res 13: 285-289.
[35] Ryall RL, Hamett RM, Hibberd CM, Edyvane
KA, Marshall VR (1989). The effect of macromolecules
on the crystallization of calcium oxalate in human urine.

crystal growth by chondroitin sulfates, heparin, pentosan
polysulfate and Tamm-Horsfall glycoprotein. In: Urolithiasis and related clinical research. Schwille PO, Smith
LH, Robertson WG, Vahlensieck W (eds.) . Plenum
Press, New York, pp. 887-890.
[7] Fellstrom B, Lindsjo M, Danielson BG,
Karlsson FA, Ljunghall S (1989) . Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation
to ionic strength. Clin Chim Acta 180: 213-220.
[8] Fellstom B, Backman U, Danielson BG,
Wikstrom B (1994). Treatment of calcium stone disease
with the synthetic glycosaminoglycan pentosan polysulfate. World J Urol 12: 52-54.
[9] Goldberg JM, Cotlier E (1972). Specific isolation and analysis of mucopolysaccharides (glycosaminoglycans) from human urine. Clin Chim Acta 41: 19-27.
[10] Grases F, Llompart I, Conte A, Coll R, March
JG (1994). Glycosaminoglycans and oxalocalcic urolithiasis. Nephron 68: 449-453.
[11] Hesse A, Wuzel H, Vahlensieck W (1986) .
The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons. Urol Int
41: 81-87.
[12] Hesse A, Wuzel H, Vahlensieck W (1991).
Significance of glycosaminoglycans for the formation of
calcium oxalate stones. Am J Kid Dis XVII: 414-419 .
[13] Hwang TIS, Preminger GM, Poindexter J, Pak
CYC (1988) . Urinary glycosaminoglycans in normal
subjects and patients with stones. J Urol 139: 995-997.
[14] Iwata H, Kamei 0 , Abe Y, Nishio S,
Wakatsuki A, Ochi K, Takeuchi M (1988). The organic
matrix of urinary uric acid crystals. J Urol 139: 607610.
[15] Khan S, Hackett RL (1993). Role of organic
matrix in urinary stone formation: An ultrastructural
study of crystal matrix interface of calcium oxalate
monohydrate stones. J Urol 150: 239-245.
[16] Kodama C, Kodama T, Yoshizawa Z (1988).
Method for analysis of urinary glycosamonoglycans. J
Chromatography 429: 293-313.
[17] Martin X, Wemess PG, Bergert JH, Smith LH
(1984) . Pentosan polysulfate as an inhibitor of calcium
oxalate crystal growth. J Urol 132: 786-788.
[18] Michelacci YM , Glashan RQ, Schor N (1989).
Urinary excretion of glycosaminoglycans in normal and
stone forming subjects. Kidney Intl 36: 1022-1028.
[19] Miyazawa K, Suzuki K, Tsugawa R (1989) .
The quantitative study of inhibitory effect of pentosan
polysulfate and chlorophyllin on the experimental calcium oxalate stone. Jpn J Urol 80: 861-869.
[20] Morse RM, Resnick MI (1988). Urinary stone
matrix. J Urol 139: 602-606.
[21] Nesse A, Garbossa G, Romero MC, Bogado
CE, Zanchetta JR (1992). Glycosaminoglycans in uro1094

Glycosaminoglycans in calcium oxalate crystal
In: Urolithiasis. Walker VR, Sutton RAL, Cameron
ECB, Pak CYC, Robertson WG (eds.). Plenum Press,
New York. pp. 133-135.
[36] Ryal! RL, Hamett RM, Hibberd CM, Edyvane
KA, Marshall VR (1991). Effect of chondroitin sulfate,
human serum albumin and Tamm-Horsfall mucoprotein
on calcium oxalate crystallization in undiluted human
urine. Urol Res 19: 181-188.
[37] Sallis JD, Lumley MF (1979). On the possible
role of glycosaminoglycans as natural inhibitors of
calcium oxalate stones. Invest Urol 16: 296-299.
[38] Sallis HD (1987). Glycosaminoglycans as
inhibitors of stone formation. Mineral Electrolyte Metab
13: 273-277.
[39] Scurr DS, Robertson WG (1986). Modifiers of
calcium oxalate crystallization found in urine. IL Studies
on their mode of action in an artificial urine. J Urol 136:
128-131.
(40] Shum DKY, Gohel MDI (1993). Separate
effects of urinary chondroitin sulfate and heparan sulfate
on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects. Clin Science 85: 33-39.
[41] Suzuki K, Miyazawa K, Tsugawa R (1989).
Inhibitory effect of sodium pentosan polysulfate on the
formation , growth and aggregation of calcium oxalate in
vitro. Jpn J Urol 80: 526-531.
(42] Suzuki K, Miyazawa K , Tsugawa R (1989). A
simple method for determining the metastable limit of
calcium oxalate. In: Urolithiasis. Walker VR, Sutton
RAL, Cameron ECB, Pak CYC, Robertson WG (eds.).
Plenum Press, New York. pp. 65-66 .
(43] Suzuki K, Moriyama M, Nakajima C, Kawamura K, Miyazawa K, Tsugawa R, Kikuchi N, Nagata
K (1994). Isolation and partial characterization of crystal
matrix protein as a potent inhibitor of calcium oxalate
crystal aggregation: evidence of activation peptide of
human prothrombin. Urol Res 22: 45-50.
[44] Suzuki K, Mayne K, Doyle IR, Ryall RL
(1994) Urinary glycosaminoglycans are selectively induced into calcium oxalate crystals precipitated from
whole human urine. Scanning Microsc 8: 523-532.
[45] Thome ID, Resnick MI (1984) A methodology
for the characterization of urinary glycosaminoglycans.
J Urol 131: 995-999.
[46] Yamaguchi S, Yoshioka T, Utsunomiya M,
Koide T, Osafune M, Okuyama A, Sonoda T (1993) .
Heparan sulfate in the matrix and its inhibitory effect on
calcium oxalate crystallization. Urol Res 21: 187-192.

were not removed by the washing treatment, e.g., because they were trapped inside aggregates? If the substances were actually inside crystals or particles, can you
tell whether they are there because they induced nucleation or because they once got adsorbed to the crystal
surface and subsequently got overgrown by crystal
material.
Authors: In this paper, crystal matrix means the
macromolecular substances derived from the CaOx crystals. Washing solution did not show any detectable
amount of GAGs or protein. Matrices are thought to
bind to the crystal surface and incorporate into the
crystals.
D. Kok: Did you perform quantitative comparisons,
and if so how were these done? If you did not do these
type of experiments, you can only state that SPP reduces
the size of the particles formed .
Authors: Crystal volume and size distribution study
between UF and SF, UF + SPP/HS showed statistically
significant results. Although it was difficult to perform
quantitative comparisons in SEM, many aggregated crystals were seen only in UF, not in SF or UF+SPP/HS .
S.R. Khan: What is the physiological concentration of
heparan sulfate in normal and stone formers urine?
What is the origin of GAGs excreted in the urine particularly the heparan sulfate? Are GAGs present as GAGs
or as a part of mucoprotein or associated with membranes etc.?
Authors: In human urine, both of normal and stone
former, the concentration of HS was calculated to be 1-2
/lg/ml (9 , 21, 22]. We did not examine the origin of HS
or other GAGs in this experiment. Further study is
needed to clarify the exact localization or characterization of HS in the kidney such as proteoglycans.
S.R. Khan: SPP 1, 2, 10 results are very close together in Figures 1 and 2, showing crystal volume and crystal number. What were the standard deviations? Was
there any significant difference between the three different amounts of SPPs used?
Authors: Statistically significant difference was observed between UF and UF+SPPl0 for crystal volume
in Figure 1 and for mean crystal size in Figure 2.
L.C. Cao and E.R. Boeve: Could the binding behavior
of urinary GAGs on CaOx crystals in this urine with
such high ionic strength be different from original urine?
Could the high oxalate concentration used to induce
CaOx crystallization influence the binding behavior of
urinary GAGs on the newly formed crystals?
Authors: Since the urine with high ionic strength and
high oxalate concentration was used, there is a possi-

Discussion with Reviewers
D. Kok: Could you please define the term "crystal matrix"? Does the crystal matrix contain molecules which
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P. Binette: Does SPP bind to other crystals?
Authors: We did not have any data of SPP about other
crystals. There are some reports about other crystals as
follows: Uric acid crystals {Grases et al. (1991) Urol
Res 19: 375-380}; and CaP crystals {Boeve et al.
(1990): Urol Res 18: 62}.

bility that binding behavior was slightly different from
original urine. But, an undiluted urine seems to be the
best system to observe the affinity of macromolecules
for CaOx crystals that might have inhibitory activity.

L.C. Cao and E.R. Boeve: The crystal matrix protein
is supposed to be selected from the urine and incorporated in newly forming CaOx crystals as reported by Ryall
in 1991. In the present manuscript, the authors describe
a similar phenomenon for HS. Can the authors comment on the reason why they have different results? Is
the HS or crystal matrix protein located on the crystal
surface only or both inside and outside the crystals?
Authors: We already reported CMP and HS coexisted
in crystal matrix extract [43]. The results of references
[43] and [44] suggests that HS and CMP adsorbed on
different binding sites; and HS and CMP were thought
to locate both inside and on the surface of the crystals.
Recently, we showed the presence of CMP using CMP
antibody and immunogold by backscattered electron
microscopy (International J Urol (1995) 2: 87-91).

P. Binette: A small percentage of SPP is secreted in
the urine. Is it bound to crystals excreted in spontaneous crystalluria?
Authors: We did not perform such an experiment yet.
P. Binette: It is stated that SPP is an anticoagulant.
What protein(s) does it bind to?
Authors: We do not know the binding protein(s) of
SPP.
R.W. Norman: Is there any evidence to suggest that
SPP might function differently in the urine of women or
male/female stone-formers as opposed to healthy controls?
Authors: To answer the question, further experiment is
needed.

M.D.I. Gobel and D.K. Y. Shum: During the isolation
of crystal matrix, the surface was washed out. The reviewers believe that if GAGs were to act as growth and/
or aggregation inhibitors, GAGs would be exerting its
influence on the surface of the crystals and not in the
crystal matrix. Those found in the crystal matrix are
possibly promotors of nucleation. Hence, the surface
washing should have been recovered for investigations
of the nature and crystallization properties of macromolecules therein.
Authors: Washing solution, which was concentrated,
electrophoresed and examined by SOS-PAGE and cellulose electrophoresis, did not show any detectable amount
of GAGs or proteins. From the results of this experiment and references [43, 44], matrices were thought to
be bound to the crystal surface and finally incorporated
into the crystals.

R.W. Norman: Do you have any evidence that oral administration of thjs drug will allow reproduction of your
findings when the drug is directly added to the pooled
urine collections?
Authors: We did not perform the experiment of oral
administration. In near future , we want to try to clarify
the usefulness of oral administration of SPP.
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